Fullhope Biomedical Co

Fullhope Biomedical Co Inventory

The Inventory of Fullhope Biomedical Co (7773.TWO) as of Nov 1, 2026 is 7.22 M TWD. In the previous year, Inventory was 6.56 M TWD — a change of 10.05% (higher).

Inventory

7.22 MTWD

YoY

10.05%

Last updated:

Inventory of Fullhope Biomedical Co is 2024 7.22 M TWD. Inventory of Fullhope Biomedical Co was 2023 6.56 M TWD. It decreases by 10.05% higher compared to the previous year.

The Fullhope Biomedical Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2022
11.81 M TWD
Jan 1, 2023
6.56 M TWD
Jan 1, 2024
7.22 M TWD
The Fullhope Biomedical Co Inventory history
YEARInventoryYoY
7.22 MTWD+10.05%
6.56 MTWD-44.48%
11.81 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fullhope Biomedical Co Stock analysis

What does Fullhope Biomedical Co do? Fullhope Biomedical Co Ltd generates revenue through precision diagnosis and regenerative medicine products. The company offers immune function analysis and circulating tumor cell analysis platforms for follow-up disease treatment strategies. In regenerative medicine, Fullhope operates a Good Tissue Practice (GTP) laboratory with a complete immune cell and stem cell manufacturing platform producing cell products. The company targets medical institutions and healthcare providers seeking advanced diagnostic and regenerative solutions. Fullhope Biomedical Co Ltd focuses on developing immune function analysis and circulating tumor cell analysis platforms within precision diagnosis. The regenerative medicine segment includes GTP-compliant laboratory services and cell product manufacturing. Medical institutions and healthcare providers are the primary customers purchasing these specialized diagnostic and regenerative medicine solutions. The company's revenue streams come from both precision diagnosis platforms and regenerative medicine services. Immune function analysis and circulating tumor cell analysis platforms provide comprehensive immune system and tumor cell data for treatment planning. GTP laboratory services and cell product manufacturing under regenerative medicine deliver specialized medical solutions to healthcare providers. Fullhope Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fullhope Biomedical Co stock

Inventory of Fullhope Biomedical Co is 7.22 M TWD in 2024.

Inventory of Fullhope Biomedical Co changed from 6.56 M TWD to 7.22 M TWD, representing a 10.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Fullhope Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Fullhope Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Fullhope Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Fullhope Biomedical Co